Abstract
An objective assessment of intraperitoneal Trasylol in the prevention of abdominal adhesions in 20 patients has shown that Trasylol resulted in a marked reduction in adhesions in 16 patients who underwent ‘second look’ procedures. No side-effects were noted and all wounds healed without complications.

This publication has 1 reference indexed in Scilit: